Abstract
Catatonia is very rare in children and adolescents, seen in only 0.6% of the inpatient population. High-dose benzodiazepines are the first-line therapy for catatonia. However, there is limited research on alternative therapies for patients who fail to respond to high-dose benzodiazepines. The objective of this study is to review the available literature on the treatment of catatonia in children and adolescents and explore potential augmentation strategies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Paper Title
Journal
Date
